{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T22:43:51Z","timestamp":1752360231785},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1067\/mjd.2000.107500","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:17:15Z","timestamp":1027556235000},"page":"708-711","source":"Crossref","is-referenced-by-count":7,"title":["The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: The need for more evidence"],"prefix":"10.1067","volume":"43","author":[{"given":"Arash","family":"Kimyai-Asadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.107500_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0190-9622(97)80329-5","article-title":"Adjuvant therapy for cutaneous malignant melanoma","volume":"36","author":"Demierre","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.107500_bib2","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1200\/JCO.1995.13.11.2776","article-title":"Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma","volume":"13","author":"Creagan","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2000.107500_bib3","first-page":"A1359","article-title":"Results of the French multicenter trial on adjuvant therapy with interferon alfa-2a in resected primary melanoma (larger than 1.5 mm) [abstract]","volume":"15","author":"Grob","year":"1996","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"10.1067\/mjd.2000.107500_bib4","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/jnci\/87.22.1710","article-title":"Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study","volume":"87","author":"Meyskens","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mjd.2000.107500_bib5","first-page":"A1296","article-title":"Evaluation of efficacy of adjuvant therapy with IFN-alpha 2a in melanoma patients with regional node metastases [abstract]","volume":"14","author":"Cascinelli","year":"1995","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"10.1067\/mjd.2000.107500_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2000.107500_bib7","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.1996.14.10.2666","article-title":"Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study","volume":"14","author":"Cole","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2000.107500_bib8","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1200\/JCO.1998.16.4.1425","article-title":"Adjuvant interferon alfa-2b treatment in resected primary stage II cutaneous melanoma","volume":"16","author":"Pehamberger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2000.107500_bib9","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2354::AID-CNCR9>3.0.CO;2-L","article-title":"Postsurgical adjuvant therapy for melanoma: evaluation of a 3-year randomized trial with recombinant interferon-? after 3 and 5 years of follow-up","volume":"79","author":"Rusciani","year":"1997","journal-title":"Cancer"},{"key":"10.1067\/mjd.2000.107500_bib10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(97)12445-X","article-title":"Randomized trial of interferon ?-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases","volume":"351","author":"Grob","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.107500_bib11","first-page":"153","article-title":"NCCN melanoma practice guidelines: National Comprehensive Cancer Network","volume":"12","author":"Houghton","year":"1998","journal-title":"Oncology"},{"key":"10.1067\/mjd.2000.107500_bib12","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archderm.134.11.1422","article-title":"Alternative medicine: is it all in your mind?","volume":"134","author":"Tausk","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107500_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0272-7358(93)90010-J","article-title":"The power of non-specific effects in healing: implications for psychosocial and biological treatments","volume":"12","author":"Roberts","year":"1993","journal-title":"Clin Psychol Rev"},{"key":"10.1067\/mjd.2000.107500_bib14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199804303381804","article-title":"Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma","volume":"338","author":"Gleave","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.107500_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.1993.01820210015002","article-title":"Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later","volume":"50","author":"Fawzy","year":"1993","journal-title":"Arch Gen Psychiatry"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200524013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200524013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T10:51:11Z","timestamp":1557399071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200524013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S0190962200524013"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.107500","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}